Literature DB >> 17940752

The role of 5-HTTLPR in choosing the lesser of two evils, the better of two goods: examining the impact of 5-HTTLPR genotype and tryptophan depletion in object choice.

K S Blair1, E Finger, A A Marsh, J Morton, K Mondillo, B Buzas, D Goldman, W C Drevets, R J R Blair.   

Abstract

RATIONALE: The serotonin (5-HT) system is considered important for decision-making. However, its role in reward- and punishment-based processing has not yet been clearly determined.
OBJECTIVES: The present study examines the effect of 5-HTTLPR genotype and tryptophan depletion on reward- and punishment-related processing, using a task that considers decision-making in situations of subtlety of choice. Thus, it considers that response choice often occurs in situations where both options are desirable (e.g., choosing between mousse au chocolat or crème caramel cheesecake from a menu) or undesirable. It also considers that response choice is easier when the reinforcements associated with the options are far apart, rather than close, in value.
MATERIALS AND METHODS: Healthy volunteers underwent acute tryptophan depletion (ATD) or control procedures and genotyping of the 5-HTTLPR for long and short allele variants. We then examined the effects and interactions of ATD and the serotonin promoter polymorphism genotype on two aspects of decision-making: (a) decision form, choosing between two objects to gain the greater reward or lesser punishment and (b) between-object reinforcement distance, the difference in reinforcements associated with two options.
RESULTS: ATD and LL homozygosity had comparable interactions with decision form and between-object reinforcement distance. Specifically, both modulated the effect of between-object reinforcement distance when deciding between objects both associated with punishment. Moreover, ATD and genotype interacted with ATD disproportionately affecting the performance of the LL homozygous group.
CONCLUSIONS: These results suggest that serotonin is particularly associated with punishment, rather than reward-related processing, and that individual sensitivity to punishment-related information and tryptophan depletion varies with genotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940752     DOI: 10.1007/s00213-007-0920-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Acute SSRI administration affects the processing of social cues in healthy volunteers.

Authors:  C J Harmer; Z Bhagwagar; D I Perrett; B A Völlm; P J Cowen; G M Goodwin
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

2.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman
Journal:  Am J Hum Genet       Date:  2006-03-28       Impact factor: 11.025

3.  A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity.

Authors:  J G Snodgrass; M Vanderwart
Journal:  J Exp Psychol Hum Learn       Date:  1980-03

4.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

5.  Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning.

Authors:  Elizabeth A T Evers; Roshan Cools; Luke Clark; Frederik M van der Veen; Jelle Jolles; Barbara J Sahakian; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2005-06       Impact factor: 7.853

6.  Acute administration of nutritionally sourced tryptophan increases fear recognition.

Authors:  M-J Attenburrow; C Williams; J Odontiadis; A Reed; J Powell; P J Cowen; C J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-29       Impact factor: 4.530

7.  A susceptibility gene for affective disorders and the response of the human amygdala.

Authors:  Ahmad R Hariri; Emily M Drabant; Karen E Munoz; Bhaskar S Kolachana; Venkata S Mattay; Michael F Egan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2005-02

8.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Monoamine depletion in psychiatric and healthy populations: review.

Authors:  L Booij; A J W Van der Does; W J Riedel
Journal:  Mol Psychiatry       Date:  2003-11       Impact factor: 15.992

10.  Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion.

Authors:  Jonathan P Roiser; Andrew D Blackwell; Roshan Cools; Luke Clark; David C Rubinsztein; Trevor W Robbins; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2006-03-15       Impact factor: 7.853

View more
  14 in total

1.  Association between the serotonin transporter triallelic genotype and eating problems is moderated by the experience of childhood trauma in women.

Authors:  Scott F Stoltenberg; Cynthia Anderson; Parthasarathi Nag; Cheryl Anagnopoulos
Journal:  Int J Eat Disord       Date:  2012-01-23       Impact factor: 4.861

2.  Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels.

Authors:  Philipp T Neukam; Nils B Kroemer; Yacila I Deza Araujo; Lydia Hellrung; Shakoor Pooseh; Marcella Rietschel; Stephanie H Witt; Uwe Schwarzenbolz; Thomas Henle; Michael N Smolka
Journal:  Psychopharmacology (Berl)       Date:  2018-05-05       Impact factor: 4.530

3.  The genetic underpinnings of callous-unemotional traits: A systematic research review.

Authors:  Ashlee A Moore; R James Blair; John M Hettema; Roxann Roberson-Nay
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 4.  The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans.

Authors:  Robert D Rogers
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

5.  Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk.

Authors:  Scott F Stoltenberg; Joanna M Vandever
Journal:  Neuropharmacology       Date:  2009-09-23       Impact factor: 5.250

6.  Genetic contributions of the serotonin transporter to social learning of fear and economic decision making.

Authors:  Liviu G Crişan; Simona Pana; Romana Vulturar; Renata M Heilman; Raluca Szekely; Bogdan Druğa; Nicolae Dragoş; Andrei C Miu
Journal:  Soc Cogn Affect Neurosci       Date:  2009-06-17       Impact factor: 3.436

7.  A genetically mediated bias in decision making driven by failure of amygdala control.

Authors:  Jonathan P Roiser; Benedetto de Martino; Geoffrey C Y Tan; Dharshan Kumaran; Ben Seymour; Nicholas W Wood; Raymond J Dolan
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 8.  The neurobiology of psychopathic traits in youths.

Authors:  R James R Blair
Journal:  Nat Rev Neurosci       Date:  2013-10-09       Impact factor: 34.870

9.  Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders.

Authors:  Gabriella Juhasz; Darragh Downey; Neal Hinvest; Emma Thomas; Diana Chase; Zoltan G Toth; Kathryn Lloyd-Williams; Krisztina Mekli; Hazel Platt; Antony Payton; Gyorgy Bagdy; Rebecca Elliott; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

10.  Serotonin Transporter Genetic Variation is Differentially Associated with Reflexive- and Reflective-Optimal Learning.

Authors:  W Todd Maddox; Marissa A Gorlick; Seth Koslov; John E McGeary; Valerie S Knopik; Christopher G Beevers
Journal:  Cereb Cortex       Date:  2017-02-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.